12:50
2026-09-01
ocregister.com
artificial-intelligence
‘I’m still here’: Patients see early promising results from new pancreatic cancer pill
The FDA approved daraxonrasib (Rasonque), a once-daily pill from Revolution Medicines for stage 4 pancreatic cancer, which nearly doubled median survival to 13.2 months from 6.7 months with chemothera…